Table 1 Association of GLUT-1 expression with clinicopathologic variables
From: Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis
Variables | GLUT-1 positive | GLUT-1 negative | n | P-value |
|---|---|---|---|---|
Age | ||||
<62 (median) | 35% | 65% | 71 | 0.01a |
≥62 (median) | 56% | 44% | 84 | |
Gender | ||||
Female | 51% | 49% | 83 | 0.57a |
Male | 43% | 57% | 73 | |
Tumor size | ||||
Mean±s.d. (cm) | 3.2±1.8 | 3.2±2.0 | 130 | 0.92c |
Stage | ||||
I, II | 40% | 54% | 98 | 0.92b |
III, IV | 52% | 33% | 23 | |
Histology/differentiation | ||||
TC | 7% | 93% | 46 | <0.001a |
AC | 21% | 79% | 29 | |
LCNEC | 74% | 26% | 23 | |
SCLC | 78% | 22% | 63 | |